Cargando…
No effect of anti-TNF-α treatment on serum IL-17 in patients with rheumatoid arthritis
INTRODUCTION: Interleukin 17 (IL-17) and CC-chemokine ligand 20 (CCL20) are increasingly implicated in the pathogenesis of rheumatoid arthritis (RA). A correlation has been reported to exist between serum levels of IL-17 and CCL20 and the disease activity. However, such an effect has not been univer...
Autores principales: | Sikorska, Dorota, Rutkowski, Rafał, Łuczak, Joanna, Samborski, Włodzimierz, Witowski, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305616/ https://www.ncbi.nlm.nih.gov/pubmed/30588171 http://dx.doi.org/10.5114/ceji.2018.80045 |
Ejemplares similares
-
Serum adiponectin as a predictor of laboratory response to anti-TNF-α therapy in rheumatoid arthritis
por: Sikorska, Dorota, et al.
Publicado: (2018) -
The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors
por: Sikorska, Dorota, et al.
Publicado: (2019) -
Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites
por: Witoszyńska-Sobkowiak, Joanna, et al.
Publicado: (2023) -
Diagnostic value of salivary CRP and IL-6 in patients undergoing anti-TNF-alpha therapy for rheumatic disease
por: Sikorska, Dorota, et al.
Publicado: (2018) -
Influence of IL10 (rs1800896) Polymorphism and TNF-α, IL-10, IL-17A, and IL-17F Serum Levels in Ankylosing Spondylitis
por: Braga, Matheus, et al.
Publicado: (2021)